Detalhe da pesquisa
1.
Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant.
Am J Hematol
; 98(1): 159-165, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35560045
2.
Adjuvant Peptide Pulsed Dendritic Cell Vaccination in Addition to T Cell Adoptive Immunotherapy for Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Biol Blood Marrow Transplant
; 24(1): 71-77, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28864137
3.
Establishment and Operation of a Third-Party Virus-Specific T Cell Bank within an Allogeneic Stem Cell Transplant Program.
Biol Blood Marrow Transplant
; 24(12): 2433-2442, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30172015
4.
Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells.
Blood
; 138(16): 1504-1509, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34010392
5.
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation.
Blood
; 121(18): 3745-58, 2013 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23435462
6.
Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
Cytotherapy
; 17(10): 1406-20, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26349000
7.
Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution.
Biol Blood Marrow Transplant
; 19(5): 725-34, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23380344
8.
In vitro generation of influenza-specific polyfunctional CD4+ T cells suitable for adoptive immunotherapy.
Cytotherapy
; 14(2): 182-93, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21954837
9.
Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients.
Cytotherapy
; 14(6): 724-32, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22404084
10.
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant.
Blood Adv
; 6(17): 4949-4966, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35819448
11.
Persistence of ex vivo expanded tumour and pathogen specific T-cells after allogeneic stem cell transplant for myeloid malignancies (the INTACT study).
Leukemia
; 37(11): 2330-2333, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37714926
12.
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells.
Blood Adv
; 1(24): 2193-2205, 2017 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29296867
13.
BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses.
Transplantation
; 92(10): 1077-84, 2011 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22002347